FOCL · Edap Tms SA
Substantial doubt about the company's ability to continue as a going concern.
“However, the Company may need to raise substantial additional financing in order to meet its cash flow needs in the subsequent period and until it achieves profitability. The Company may not be able to raise additional financing on acceptable terms or at all and this condition may in the future raise uncertainty regarding its ability to continue as a going concern.”View the 10-Q filed May 7, 2026
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Recent news
| Date | Headline |
|---|---|
| 2026-06-30 |
FocalTherics™ Announces Successful Launch of First Commercial Endometriosis Focal One® Program in Europe with Treatment of Initial Patients
FocalTherics™ Announces Successful Launch of First Commercial Endometriosis Focal One® Program in Europe with Treatment of Initial Patients AUSTIN, Texas, June 30, 2026 (GLOBE NEWSWIRE) -- FocalTherics™ (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced the |
| 2026-06-16 |
FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical
FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical AUSTIN, Texas, June 16, 2026 (GLOBE NEWSWIRE) -- FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it has |
| 2026-05-29 |
EDAP Announces Corporate Name Change to FocalTherics™ to Reflect Exclusive Focus on High-Growth Robotic Focal Therapy
EDAP Announces Corporate Name Change to FocalTherics ™ to Reflect Exclusive Focus on High-Growth Robotic Focal Therapy Company will Begin Trading Under New Ticker Symbol “FOCL” at Market Open on June 1, 2026 Company Intends to Report and Classify its Legacy |
| 2026-05-21 |
EDAP | Focal One to Present at Jefferies 2026 Global Healthcare Conference
EDAP | Focal One to Present at Jefferies 2026 Global Healthcare Conference Company to Present and Host 1x1 Investor Meetings on Thursday, June 4 th, 2026 AUSTIN, Texas, May 21 th, 2026 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic |
| 2026-05-14 |
EDAP | Focal One and Telix Announce Collaboration Focused on Robotic HIFU and Theranostics in Prostate Cancer
EDAP | Focal One and Telix Announce Collaboration Focused on Robotic HIFU and Theranostics in Prostate Cancer AUSTIN, Texas – May 14, 2026 – EDAP TMS S.A. (Nasdaq: EDAP) today announced that it has entered into a letter of intent with Telix Pharmaceuticals Limited (“Telix”) to explore joint clinical research activities and physician education focused on the combination of |
| 2026-05-13 |
EDAP | Focal One to Host Investor Day on June 1, 2026
EDAP | Focal One to Host Investor Day on June 1, 2026 AUSTIN, Texas, May 13, 2026 -- EDAP TMS SA (Nasdaq: EDAP) (the “Company”), the global leader in robotic energy-based therapies, today announced that it will host an Investor Day for analysts and investors at |
| 2026-05-07 |
EDAP Reports Strong Financial Results with Record First Quarter HIFU Revenue
EDAP Reports Strong Financial Results with Record First Quarter HIFU Revenue Seventh Consecutive Quarter of Year-Over-Year HIFU Revenue Growth 78% Growth in First Quarter HIFU Revenue Year-Over-Year 53% Growth in First Quarter U.S. |
| 2026-04-30 |
EDAP TMS Strengthens Market Position with Landmark HIFI-2 Data Supporting Focal One® Robotic HIFU in Radiorecurrent Prostate Cancer
EDAP TMS Strengthens Market Position with Landmark HIFI-2 Data Supporting Focal One ® Robotic HIFU in Radiorecurrent Prostate Cancer AUSTIN, Texas, April 30, 2026 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced |
| 2026-04-16 |
EDAP to Announce First Quarter 2026 Financial Results on May 7, 2026
EDAP to Announce First Quarter 2026 Financial Results on May 7, 2026 Company to host conference call and webcast on Thursday, May 7 at 8:30 a.m. EDT AUSTIN, Texas, April 16, 2026 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic |
| 2026-03-25 |
EDAP Reports Record Fourth Quarter and Full-Year 2025 HIFU Revenue
EDAP Reports Record Fourth Quarter and Full-Year 2025 HIFU Revenue 39% Full-Year YoY HIFU Revenue Growth, Record Performance Driven by Increased Focal One® System Sales and Growth in the Number of U.S. Focal One Procedures 69% Full-Year YoY Growth in Focal One System Placements 28% Q4 YoY Growth in |
Past events
| Date | Event | Type |
|---|---|---|
| 2026-06-04 | EDAP to Present at Jefferies Global Healthcare Conference in New York | Conference |
| 2026-06-01 | Focal One Investor Day | Presentation |
| 2026-05-07 | EDAP TMS First Quarter 2026 Earnings Conference Call | Earnings call |
| 2026-03-25 | EDAP TMS Fourth Quarter 2025 Earnings Conference Call | Earnings call |
| 2026-03-18 | EDAP to Present at Oppenheimer 36th Annual Healthcare MedTech & Services Conference | Conference |
| 2025-11-18 | EDAP to Present at Jefferies Global Healthcare Conference in London | Conference |
| 2025-11-10 | EDAP to Participate in the UBS Global Healthcare Conference | Conference |
| 2025-11-06 | EDAP TMS Third Quarter 2025 Earnings Conference Call | Earnings call |
| 2025-09-09 | EDAP to Participate in the H.C. Wainwright 27th Annual Global Investment Conference | Conference |
| 2025-08-28 | EDAP TMS Second Quarter 2025 Earnings Conference Call | Earnings call |
Source: https://investor.focalone.com/